AJP - Lung Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Lung Cell Mol Physiol 261: L240-L248, 1991;
1040-0605/91 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Idell, S.
Right arrow Articles by Maunder, R. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Idell, S.
Right arrow Articles by Maunder, R. J.

AJP - Lung Cellular and Molecular Physiology, Vol 261, Issue 4 240-L248, Copyright © 1991 by American Physiological Society


ARTICLES

Serial abnormalities of fibrin turnover in evolving adult respiratory distress syndrome

S. Idell, K. B. Koenig, D. S. Fair, T. R. Martin, J. McLarty and R. J. Maunder
University of Texas Health Center, Tyler 75710.

We studied the changes of coagulation and fibrinolysis in bronchoalveolar lavage (BAL) and plasma obtained serially at intervals after the onset of adult respiratory distress syndrome (ARDS). BAL procoagulant activity was increased at 3 days and tended to decrease thereafter. Tissue factor associated with factor VII was the major BAL procoagulant. Fibrinopeptide A was increased, indicating increased thrombin-mediated conversion of fibrinogen to fibrin. Fibrinolytic activity was usually undetectable in BAL at 3 days post-ARDS and remained depressed for up to 14 days despite unchanged concentrations of urokinase and variably detectable tissue plasminogen activator. Depressed fibrinolytic activity was associated with increased antiplasmin activity and plasminogen activator inhibitor 1 (PAI-1) while PAI-2 concentrations approximated those of control samples and did not change during evolving ARDS. Evidence of systemic coagulopathy and increased systemic fibrin degradation were commonly found in serial ARDS plasma samples, consistent with accelerated vascular and/or extravascular fibrin deposition in these patients. The data indicate that intra-alveolar as well as systemic derangements of fibrin turnover are common features of evolving ARDS. Concurrent local abnormalities of both coagulation and fibrinolytic pathways favor persistence of alveolar fibrin for up to 14 days after clinical recognition of ARDS.


This article has been cited by other articles:


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
J. A. Bastarache, L. Wang, Z. Wang, K. H. Albertine, M. A. Matthay, and L. B. Ware
Intra-alveolar tissue factor pathway inhibitor is not sufficient to block tissue factor procoagulant activity
Am J Physiol Lung Cell Mol Physiol, May 1, 2008; 294(5): L874 - L881.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
A. Chan, K. Jayasuriya, L. Berry, M. Roth-Kleiner, M. Post, and J. Belik
Volutrauma activates the clotting cascade in the newborn but not adult rat
Am J Physiol Lung Cell Mol Physiol, April 1, 2006; 290(4): L754 - L760.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
S. A. J. ter Horst, G. T. M. Wagenaar, E. de Boer, M. A. van Gastelen, J. C. M. Meijers, B. J. Biemond, B. J. H. M. Poorthuis, and F. J. Walther
Pentoxifylline reduces fibrin deposition and prolongs survival in neonatal hyperoxic lung injury
J Appl Physiol, November 1, 2004; 97(5): 2014 - 2019.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
L. B. Ware, X. Fang, and M. A. Matthay
Protein C and thrombomodulin in human acute lung injury
Am J Physiol Lung Cell Mol Physiol, September 1, 2003; 285(3): L514 - L521.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
P. Prabhakaran, L. B. Ware, K. E. White, M. T. Cross, M. A. Matthay, and M. A. Olman
Elevated levels of plasminogen activator inhibitor-1 in pulmonary edema fluid are associated with mortality in acute lung injury
Am J Physiol Lung Cell Mol Physiol, July 1, 2003; 285(1): L20 - L28.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
P. Markart, C. Ruppert, F. Grimminger, W. Seeger, and A. Gunther
Fibrinolysis-inhibitory capacity of clot-embedded surfactant is enhanced by SP-B and SP-C
Am J Physiol Lung Cell Mol Physiol, January 1, 2003; 284(1): L69 - L76.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
T. H. Sisson, K. E. Hanson, N. Subbotina, A. Patwardhan, N. Hattori, and R. H. Simon
Inducible lung-specific urokinase expression reduces fibrosis and mortality after lung injury in mice
Am J Physiol Lung Cell Mol Physiol, November 1, 2002; 283(5): L1023 - L1032.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
S. IDELL
Anticoagulants for Acute Respiratory Distress Syndrome . Can They Work?
Am. J. Respir. Crit. Care Med., August 15, 2001; 164(4): 517 - 520.
[Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
R. T. Schermuly, A. Gunther, M. Ermert, L. Ermert, H. A. Ghofrani, N. Weissmann, F. Grimminger, W. Seeger, and D. Walmrath
Conebulization of surfactant and urokinase restores gas exchange in perfused lungs with alveolar fibrin formation
Am J Physiol Lung Cell Mol Physiol, April 1, 2001; 280(4): L792 - L800.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
M. R. Horton, M. A. Olman, C. Bao, K. E. White, A. M. K. Choi, B.-Y. Chin, P. W. Noble, and C. J. Lowenstein
Regulation of plasminogen activator inhibitor-1 and urokinase by hyaluronan fragments in mouse macrophages
Am J Physiol Lung Cell Mol Physiol, October 1, 2000; 279(4): L707 - L715.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
M. D. Gole, J. M. Souza, I. Choi, C. Hertkorn, S. Malcolm, R. F. Foust III, B. Finkel, P. N. Lanken, and H. Ischiropoulos
Plasma proteins modified by tyrosine nitration in acute respiratory distress syndrome
Am J Physiol Lung Cell Mol Physiol, May 1, 2000; 278(5): L961 - L967.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
E. Abraham
Coagulation Abnormalities in Acute Lung Injury and Sepsis
Am. J. Respir. Cell Mol. Biol., April 1, 2000; 22(4): 401 - 404.
[Full Text]


Home page
Am. J. Respir. Crit. Care Med.Home page
A. GÜNTHER, P. MOSAVI, S. HEINEMANN, C. RUPPERT, H. MUTH, P. MARKART, F. GRIMMINGER, D. WALMRATH, B. TEMMESFELD-WOLLBRÜCK, and W. SEEGER
Alveolar Fibrin Formation Caused by Enhanced Procoagulant and Depressed Fibrinolytic Capacities in Severe Pneumonia . Comparison with the Acute Respiratory Distress Syndrome
Am. J. Respir. Crit. Care Med., February 1, 2000; 161(2): 454 - 462.
[Abstract] [Full Text]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
A. Günther, P. Markart, M. Kalinowski, C. Ruppert, F. Grimminger, and W. Seeger
Cleavage of Surfactant-Incorporating Fibrin by Different Fibrinolytic Agents . Kinetics of Lysis and Rescue of Surface Activity
Am. J. Respir. Cell Mol. Biol., December 1, 1999; 21(6): 738 - 745.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
A. Elssner, G. Mazur, and C. Vogelmeier
Inhibition of factor XIIIa-mediated incorporation of fibronectin into fibrin by pulmonary surfactant
Am J Physiol Lung Cell Mol Physiol, April 1, 1999; 276(4): L625 - L630.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
R. MARSHALL, G. BELLINGAN, and G. LAURENT
The acute respiratory distress syndrome: fibrosis in the fast lane
Thorax, October 1, 1998; 53(10): 815 - 817.
[Full Text]


Home page
Infect. Immun.Home page
P. J. Simpson-Haidaris, M.-A. Courtney, T. W. Wright, R. Goss, A. Harmsen, and F. Gigliotti
Induction of Fibrinogen Expression in the Lung Epithelium during Pneumocystis carinii Pneumonia
Infect. Immun., September 1, 1998; 66(9): 4431 - 4439.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
M. LEVI, T. van der POLL, H. ten CATE, B. KUIPERS, B. J. BIEMOND, H. M. JANSEN, and J. W. ten CATE
Differential Effects of Anti-cytokine Treatment on Bronchoalveolar Hemostasis in Endotoxemic Chimpanzees
Am. J. Respir. Crit. Care Med., July 1, 1998; 158(1): 92 - 98.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online